Skip to content
About Us
History
Leadership
Scientific Advisory Board
Collaboration and Partnership
Locations
Our Science
Small Molecules
ADC Platform
Pipeline
Small Molecules
Kinases
Encorafenib (BRAF)
Entrectinib (TRK, ROS)
Onvansertib (PLK1)
NMS-153 (MPS1)
NMS-812 (PERK/ GCN2)
Early Pipeline Projects
NAD+ Binding Family: PARP
NMS-293 (PARP1)
Atamparib (PARP7)
ADC Platform
Peptide Drug Conjugate (PDC)
Antibody Drug Conjugate (ADC)
Platform of Payload- Linkers
News/Events & Publications
News
Events
Publications
Careers
Contact Us
Menu
About Us
History
Leadership
Scientific Advisory Board
Collaboration and Partnership
Locations
Our Science
Small Molecules
ADC Platform
Pipeline
Small Molecules
Kinases
Encorafenib (BRAF)
Entrectinib (TRK, ROS)
Onvansertib (PLK1)
NMS-153 (MPS1)
NMS-812 (PERK/ GCN2)
Early Pipeline Projects
NAD+ Binding Family: PARP
NMS-293 (PARP1)
Atamparib (PARP7)
ADC Platform
Peptide Drug Conjugate (PDC)
Antibody Drug Conjugate (ADC)
Platform of Payload- Linkers
News/Events & Publications
News
Events
Publications
Careers
Contact Us
Search
Search
Close this search box.
15th Annual PEGS Boston
Home
/
15th Annual PEGS Boston
April 8-12
Boston, MA, USA
15th Annual PEGS Boston
Keystone symposium Proteomics and its Application to Translational and Precision Medicine
Terapie personalizzate nelle neoplasie mieloidi
Share this page
Facebook
Twitter
LinkedIn
Email
svg.e-font-icon-svg {display:none!important} .elementor-button-icon {display:none!important} .show-more, .show-more2 {display:none!important} img.pf-large-image.pf-primary-img.flex-width.pf-size-full.blockImage { display: none!important; }